Last reviewed · How we verify

NCT06936852

Ultrasound Guided Serratus Posterior Superior Intercostal Plane Versus PECS II Block In Breast Surgeries

Completed NA Last updated 17 April 2026
What this trial tests

NA trial testing Serratus posterior superior intercostal plane block in Analgesia in 100 participants. Completed in 27 March 2026.

Timeline
27 February 2025
Primary endpoint
27 September 2025
27 March 2026

Quick facts

Lead sponsorTanta University
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingdouble
Primary purposeprevention
Enrollment100
Start date27 February 2025
Primary completion27 September 2025
Estimated completion27 March 2026
Sites1 location across Egypt

Drugs / interventions tested

Conditions studied

Sponsor

Tanta University

Who can join

Adults 21 to 70, any sex, with Analgesia. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aim of the study is to compare the analgesic effect of ultrasound guided serratus posterior superior intercostal plane (SPSIP) block and pectoral nerve (PECS II) block in different breast surgeries.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Serratus posterior superior intercostal plane block

Trials testing the same drug.

Other recruiting trials for Analgesia

Currently open trials in the same condition.

Other Tanta University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06936852.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing